CanSino Biologics Inc.
CanSino Biologics Inc. (CASBF) Stock Competitors & Peer Comparison
See (CASBF) competitors and their performances in Stock Market.
Peer Comparison Table: Drug Manufacturers - Specialty & Generic Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| CASBF | $6.26 | +0.00% | 2.2B | -29.81 | -$0.21 | N/A |
| MKGAF | $126.45 | -4.62% | 58.4B | 17.51 | $7.67 | +1.87% |
| MKKGY | $26.08 | +0.77% | 57.2B | 17.20 | $1.53 | +1.90% |
| TKPHF | $31.00 | +13.35% | 48.4B | 53.45 | $0.58 | +4.29% |
| IPSEY | $34.09 | +0.96% | 45.1B | 21.85 | $1.56 | +0.76% |
| HLNCF | $4.92 | +0.41% | 44.1B | 21.37 | $0.23 | +2.06% |
| SDZNY | $62.96 | +3.67% | 27.1B | 121.15 | $0.52 | +1.08% |
| ESALY | $61.51 | -2.11% | 17.6B | 20.54 | $3.00 | N/A |
| TEVJF | $14.32 | +0.00% | 16.4B | -95.47 | -$0.15 | N/A |
| SGIOF | $17.70 | -6.84% | 15.1B | 13.01 | $1.36 | +4.60% |
Stock Comparison
CASBF vs MKGAF Comparison August 2025
CASBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CASBF stands at 2.2B. In comparison, MKGAF has a market cap of 58.4B. Regarding current trading prices, CASBF is priced at $6.26, while MKGAF trades at $126.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CASBF currently has a P/E ratio of -29.81, whereas MKGAF's P/E ratio is 17.51. In terms of profitability, CASBF's ROE is -0.04%, compared to MKGAF's ROE of +0.10%. Regarding short-term risk, CASBF and MKGAF have similar daily volatility (0.00).Check MKGAF's competition here
CASBF vs MKKGY Comparison August 2025
CASBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CASBF stands at 2.2B. In comparison, MKKGY has a market cap of 57.2B. Regarding current trading prices, CASBF is priced at $6.26, while MKKGY trades at $26.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CASBF currently has a P/E ratio of -29.81, whereas MKKGY's P/E ratio is 17.20. In terms of profitability, CASBF's ROE is -0.04%, compared to MKKGY's ROE of +0.10%. Regarding short-term risk, CASBF and MKKGY have similar daily volatility (0.00).Check MKKGY's competition here
CASBF vs TKPHF Comparison August 2025
CASBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CASBF stands at 2.2B. In comparison, TKPHF has a market cap of 48.4B. Regarding current trading prices, CASBF is priced at $6.26, while TKPHF trades at $31.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CASBF currently has a P/E ratio of -29.81, whereas TKPHF's P/E ratio is 53.45. In terms of profitability, CASBF's ROE is -0.04%, compared to TKPHF's ROE of +0.02%. Regarding short-term risk, CASBF and TKPHF have similar daily volatility (0.00).Check TKPHF's competition here
CASBF vs IPSEY Comparison August 2025
CASBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CASBF stands at 2.2B. In comparison, IPSEY has a market cap of 45.1B. Regarding current trading prices, CASBF is priced at $6.26, while IPSEY trades at $34.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CASBF currently has a P/E ratio of -29.81, whereas IPSEY's P/E ratio is 21.85. In terms of profitability, CASBF's ROE is -0.04%, compared to IPSEY's ROE of +0.08%. Regarding short-term risk, CASBF and IPSEY have similar daily volatility (0.00).Check IPSEY's competition here
CASBF vs HLNCF Comparison August 2025
CASBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CASBF stands at 2.2B. In comparison, HLNCF has a market cap of 44.1B. Regarding current trading prices, CASBF is priced at $6.26, while HLNCF trades at $4.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CASBF currently has a P/E ratio of -29.81, whereas HLNCF's P/E ratio is 21.37. In terms of profitability, CASBF's ROE is -0.04%, compared to HLNCF's ROE of +0.09%. Regarding short-term risk, CASBF is less volatile compared to HLNCF. This indicates potentially lower risk in terms of short-term price fluctuations for CASBF.Check HLNCF's competition here
CASBF vs SDZNY Comparison August 2025
CASBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CASBF stands at 2.2B. In comparison, SDZNY has a market cap of 27.1B. Regarding current trading prices, CASBF is priced at $6.26, while SDZNY trades at $62.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CASBF currently has a P/E ratio of -29.81, whereas SDZNY's P/E ratio is 121.15. In terms of profitability, CASBF's ROE is -0.04%, compared to SDZNY's ROE of +0.00%. Regarding short-term risk, CASBF is less volatile compared to SDZNY. This indicates potentially lower risk in terms of short-term price fluctuations for CASBF.Check SDZNY's competition here
CASBF vs ESALY Comparison August 2025
CASBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CASBF stands at 2.2B. In comparison, ESALY has a market cap of 17.6B. Regarding current trading prices, CASBF is priced at $6.26, while ESALY trades at $61.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CASBF currently has a P/E ratio of -29.81, whereas ESALY's P/E ratio is 20.54. In terms of profitability, CASBF's ROE is -0.04%, compared to ESALY's ROE of +0.06%. Regarding short-term risk, CASBF is less volatile compared to ESALY. This indicates potentially lower risk in terms of short-term price fluctuations for CASBF.Check ESALY's competition here
CASBF vs TEVJF Comparison August 2025
CASBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CASBF stands at 2.2B. In comparison, TEVJF has a market cap of 16.4B. Regarding current trading prices, CASBF is priced at $6.26, while TEVJF trades at $14.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CASBF currently has a P/E ratio of -29.81, whereas TEVJF's P/E ratio is -95.47. In terms of profitability, CASBF's ROE is -0.04%, compared to TEVJF's ROE of -0.03%. Regarding short-term risk, CASBF is less volatile compared to TEVJF. This indicates potentially lower risk in terms of short-term price fluctuations for CASBF.Check TEVJF's competition here
CASBF vs SGIOF Comparison August 2025
CASBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CASBF stands at 2.2B. In comparison, SGIOF has a market cap of 15.1B. Regarding current trading prices, CASBF is priced at $6.26, while SGIOF trades at $17.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CASBF currently has a P/E ratio of -29.81, whereas SGIOF's P/E ratio is 13.01. In terms of profitability, CASBF's ROE is -0.04%, compared to SGIOF's ROE of +0.05%. Regarding short-term risk, CASBF and SGIOF have similar daily volatility (0.00).Check SGIOF's competition here
CASBF vs SGIOY Comparison August 2025
CASBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CASBF stands at 2.2B. In comparison, SGIOY has a market cap of 15B. Regarding current trading prices, CASBF is priced at $6.26, while SGIOY trades at $8.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CASBF currently has a P/E ratio of -29.81, whereas SGIOY's P/E ratio is 12.94. In terms of profitability, CASBF's ROE is -0.04%, compared to SGIOY's ROE of +0.05%. Regarding short-term risk, CASBF and SGIOY have similar daily volatility (0.00).Check SGIOY's competition here
CASBF vs BIOVF Comparison August 2025
CASBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CASBF stands at 2.2B. In comparison, BIOVF has a market cap of 10.6B. Regarding current trading prices, CASBF is priced at $6.26, while BIOVF trades at $30.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CASBF currently has a P/E ratio of -29.81, whereas BIOVF's P/E ratio is 23.47. In terms of profitability, CASBF's ROE is -0.04%, compared to BIOVF's ROE of +0.11%. Regarding short-term risk, CASBF is less volatile compared to BIOVF. This indicates potentially lower risk in terms of short-term price fluctuations for CASBF.Check BIOVF's competition here
CASBF vs SFOSF Comparison August 2025
CASBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CASBF stands at 2.2B. In comparison, SFOSF has a market cap of 9.7B. Regarding current trading prices, CASBF is priced at $6.26, while SFOSF trades at $2.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CASBF currently has a P/E ratio of -29.81, whereas SFOSF's P/E ratio is 15.33. In terms of profitability, CASBF's ROE is -0.04%, compared to SFOSF's ROE of +0.06%. Regarding short-term risk, CASBF and SFOSF have similar daily volatility (0.00).Check SFOSF's competition here
CASBF vs IPSEF Comparison August 2025
CASBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CASBF stands at 2.2B. In comparison, IPSEF has a market cap of 9.4B. Regarding current trading prices, CASBF is priced at $6.26, while IPSEF trades at $113.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CASBF currently has a P/E ratio of -29.81, whereas IPSEF's P/E ratio is 18.07. In terms of profitability, CASBF's ROE is -0.04%, compared to IPSEF's ROE of +0.08%. Regarding short-term risk, CASBF is less volatile compared to IPSEF. This indicates potentially lower risk in terms of short-term price fluctuations for CASBF.Check IPSEF's competition here
CASBF vs ESAIY Comparison August 2025
CASBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CASBF stands at 2.2B. In comparison, ESAIY has a market cap of 9B. Regarding current trading prices, CASBF is priced at $6.26, while ESAIY trades at $8.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CASBF currently has a P/E ratio of -29.81, whereas ESAIY's P/E ratio is 28.43. In terms of profitability, CASBF's ROE is -0.04%, compared to ESAIY's ROE of +0.03%. Regarding short-term risk, CASBF and ESAIY have similar daily volatility (0.00).Check ESAIY's competition here
CASBF vs ESALF Comparison August 2025
CASBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CASBF stands at 2.2B. In comparison, ESALF has a market cap of 9B. Regarding current trading prices, CASBF is priced at $6.26, while ESALF trades at $31.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CASBF currently has a P/E ratio of -29.81, whereas ESALF's P/E ratio is 28.72. In terms of profitability, CASBF's ROE is -0.04%, compared to ESALF's ROE of +0.03%. Regarding short-term risk, CASBF and ESALF have similar daily volatility (0.00).Check ESALF's competition here
CASBF vs GZPHF Comparison August 2025
CASBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CASBF stands at 2.2B. In comparison, GZPHF has a market cap of 5.9B. Regarding current trading prices, CASBF is priced at $6.26, while GZPHF trades at $2.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CASBF currently has a P/E ratio of -29.81, whereas GZPHF's P/E ratio is 9.79. In terms of profitability, CASBF's ROE is -0.04%, compared to GZPHF's ROE of +0.07%. Regarding short-term risk, CASBF is less volatile compared to GZPHF. This indicates potentially lower risk in terms of short-term price fluctuations for CASBF.Check GZPHF's competition here
CASBF vs HKMPF Comparison August 2025
CASBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CASBF stands at 2.2B. In comparison, HKMPF has a market cap of 5.4B. Regarding current trading prices, CASBF is priced at $6.26, while HKMPF trades at $24.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CASBF currently has a P/E ratio of -29.81, whereas HKMPF's P/E ratio is 14.59. In terms of profitability, CASBF's ROE is -0.04%, compared to HKMPF's ROE of +0.16%. Regarding short-term risk, CASBF and HKMPF have similar daily volatility (0.00).Check HKMPF's competition here
CASBF vs HKMPY Comparison August 2025
CASBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CASBF stands at 2.2B. In comparison, HKMPY has a market cap of 5.3B. Regarding current trading prices, CASBF is priced at $6.26, while HKMPY trades at $48.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CASBF currently has a P/E ratio of -29.81, whereas HKMPY's P/E ratio is 14.45. In terms of profitability, CASBF's ROE is -0.04%, compared to HKMPY's ROE of +0.16%. Regarding short-term risk, CASBF and HKMPY have similar daily volatility (0.00).Check HKMPY's competition here
CASBF vs SGFEF Comparison August 2025
CASBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CASBF stands at 2.2B. In comparison, SGFEF has a market cap of 5B. Regarding current trading prices, CASBF is priced at $6.26, while SGFEF trades at $114.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CASBF currently has a P/E ratio of -29.81, whereas SGFEF's P/E ratio is 25.08. In terms of profitability, CASBF's ROE is -0.04%, compared to SGFEF's ROE of +0.17%. Regarding short-term risk, CASBF is less volatile compared to SGFEF. This indicates potentially lower risk in terms of short-term price fluctuations for CASBF.Check SGFEF's competition here
CASBF vs WIBFF Comparison August 2025
CASBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CASBF stands at 2.2B. In comparison, WIBFF has a market cap of 5B. Regarding current trading prices, CASBF is priced at $6.26, while WIBFF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CASBF currently has a P/E ratio of -29.81, whereas WIBFF's P/E ratio is -0.01. In terms of profitability, CASBF's ROE is -0.04%, compared to WIBFF's ROE of +0.00%. Regarding short-term risk, CASBF is less volatile compared to WIBFF. This indicates potentially lower risk in terms of short-term price fluctuations for CASBF.Check WIBFF's competition here
CASBF vs HLUBF Comparison August 2025
CASBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CASBF stands at 2.2B. In comparison, HLUBF has a market cap of 4.9B. Regarding current trading prices, CASBF is priced at $6.26, while HLUBF trades at $4.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CASBF currently has a P/E ratio of -29.81, whereas HLUBF's P/E ratio is 9.04. In terms of profitability, CASBF's ROE is -0.04%, compared to HLUBF's ROE of +0.14%. Regarding short-term risk, CASBF and HLUBF have similar daily volatility (0.00).Check HLUBF's competition here
CASBF vs HLBBF Comparison August 2025
CASBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CASBF stands at 2.2B. In comparison, HLBBF has a market cap of 4.4B. Regarding current trading prices, CASBF is priced at $6.26, while HLBBF trades at $5.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CASBF currently has a P/E ratio of -29.81, whereas HLBBF's P/E ratio is 10.03. In terms of profitability, CASBF's ROE is -0.04%, compared to HLBBF's ROE of +0.14%. Regarding short-term risk, CASBF is less volatile compared to HLBBF. This indicates potentially lower risk in terms of short-term price fluctuations for CASBF.Check HLBBF's competition here
CASBF vs LVZPF Comparison August 2025
CASBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CASBF stands at 2.2B. In comparison, LVZPF has a market cap of 4B. Regarding current trading prices, CASBF is priced at $6.26, while LVZPF trades at $3.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CASBF currently has a P/E ratio of -29.81, whereas LVZPF's P/E ratio is 11.43. In terms of profitability, CASBF's ROE is -0.04%, compared to LVZPF's ROE of +0.15%. Regarding short-term risk, CASBF is less volatile compared to LVZPF. This indicates potentially lower risk in terms of short-term price fluctuations for CASBF.Check LVZPF's competition here
CASBF vs SMDPY Comparison August 2025
CASBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CASBF stands at 2.2B. In comparison, SMDPY has a market cap of 4B. Regarding current trading prices, CASBF is priced at $6.26, while SMDPY trades at $10.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CASBF currently has a P/E ratio of -29.81, whereas SMDPY's P/E ratio is 25.00. In terms of profitability, CASBF's ROE is -0.04%, compared to SMDPY's ROE of +0.15%. Regarding short-term risk, CASBF is less volatile compared to SMDPY. This indicates potentially lower risk in terms of short-term price fluctuations for CASBF.Check SMDPY's competition here
CASBF vs DNPUF Comparison August 2025
CASBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CASBF stands at 2.2B. In comparison, DNPUF has a market cap of 3.6B. Regarding current trading prices, CASBF is priced at $6.26, while DNPUF trades at $8.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CASBF currently has a P/E ratio of -29.81, whereas DNPUF's P/E ratio is 22.43. In terms of profitability, CASBF's ROE is -0.04%, compared to DNPUF's ROE of +0.15%. Regarding short-term risk, CASBF is less volatile compared to DNPUF. This indicates potentially lower risk in terms of short-term price fluctuations for CASBF.Check DNPUF's competition here
CASBF vs CHSYF Comparison August 2025
CASBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CASBF stands at 2.2B. In comparison, CHSYF has a market cap of 3.3B. Regarding current trading prices, CASBF is priced at $6.26, while CHSYF trades at $1.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CASBF currently has a P/E ratio of -29.81, whereas CHSYF's P/E ratio is 13.50. In terms of profitability, CASBF's ROE is -0.04%, compared to CHSYF's ROE of +0.10%. Regarding short-term risk, CASBF is less volatile compared to CHSYF. This indicates potentially lower risk in terms of short-term price fluctuations for CASBF.Check CHSYF's competition here
CASBF vs ULIHF Comparison August 2025
CASBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CASBF stands at 2.2B. In comparison, ULIHF has a market cap of 3.2B. Regarding current trading prices, CASBF is priced at $6.26, while ULIHF trades at $1.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CASBF currently has a P/E ratio of -29.81, whereas ULIHF's P/E ratio is 8.20. In terms of profitability, CASBF's ROE is -0.04%, compared to ULIHF's ROE of +0.20%. Regarding short-term risk, CASBF is less volatile compared to ULIHF. This indicates potentially lower risk in terms of short-term price fluctuations for CASBF.Check ULIHF's competition here
CASBF vs APNHF Comparison August 2025
CASBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CASBF stands at 2.2B. In comparison, APNHF has a market cap of 3.2B. Regarding current trading prices, CASBF is priced at $6.26, while APNHF trades at $7.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CASBF currently has a P/E ratio of -29.81, whereas APNHF's P/E ratio is 12.72. In terms of profitability, CASBF's ROE is -0.04%, compared to APNHF's ROE of +0.05%. Regarding short-term risk, CASBF is less volatile compared to APNHF. This indicates potentially lower risk in terms of short-term price fluctuations for CASBF.Check APNHF's competition here
CASBF vs INVVY Comparison August 2025
CASBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CASBF stands at 2.2B. In comparison, INVVY has a market cap of 3B. Regarding current trading prices, CASBF is priced at $6.26, while INVVY trades at $21.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CASBF currently has a P/E ratio of -29.81, whereas INVVY's P/E ratio is -62.42. In terms of profitability, CASBF's ROE is -0.04%, compared to INVVY's ROE of -0.48%. Regarding short-term risk, CASBF and INVVY have similar daily volatility (0.00).Check INVVY's competition here
CASBF vs IZQVF Comparison August 2025
CASBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CASBF stands at 2.2B. In comparison, IZQVF has a market cap of 2.9B. Regarding current trading prices, CASBF is priced at $6.26, while IZQVF trades at $20.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CASBF currently has a P/E ratio of -29.81, whereas IZQVF's P/E ratio is -56.68. In terms of profitability, CASBF's ROE is -0.04%, compared to IZQVF's ROE of -0.48%. Regarding short-term risk, CASBF and IZQVF have similar daily volatility (0.00).Check IZQVF's competition here
CASBF vs LBTSF Comparison August 2025
CASBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CASBF stands at 2.2B. In comparison, LBTSF has a market cap of 2.9B. Regarding current trading prices, CASBF is priced at $6.26, while LBTSF trades at $13.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CASBF currently has a P/E ratio of -29.81, whereas LBTSF's P/E ratio is 121.45. In terms of profitability, CASBF's ROE is -0.04%, compared to LBTSF's ROE of +0.01%. Regarding short-term risk, CASBF is less volatile compared to LBTSF. This indicates potentially lower risk in terms of short-term price fluctuations for CASBF.Check LBTSF's competition here
CASBF vs HMDCF Comparison August 2025
CASBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CASBF stands at 2.2B. In comparison, HMDCF has a market cap of 2.8B. Regarding current trading prices, CASBF is priced at $6.26, while HMDCF trades at $3.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CASBF currently has a P/E ratio of -29.81, whereas HMDCF's P/E ratio is -64.10. In terms of profitability, CASBF's ROE is -0.04%, compared to HMDCF's ROE of +0.03%. Regarding short-term risk, CASBF is less volatile compared to HMDCF. This indicates potentially lower risk in terms of short-term price fluctuations for CASBF.Check HMDCF's competition here
CASBF vs HYPMY Comparison August 2025
CASBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CASBF stands at 2.2B. In comparison, HYPMY has a market cap of 2.8B. Regarding current trading prices, CASBF is priced at $6.26, while HYPMY trades at $4.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CASBF currently has a P/E ratio of -29.81, whereas HYPMY's P/E ratio is 20.90. In terms of profitability, CASBF's ROE is -0.04%, compared to HYPMY's ROE of +0.06%. Regarding short-term risk, CASBF is less volatile compared to HYPMY. This indicates potentially lower risk in terms of short-term price fluctuations for CASBF.Check HYPMY's competition here
CASBF vs APNHY Comparison August 2025
CASBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CASBF stands at 2.2B. In comparison, APNHY has a market cap of 2.6B. Regarding current trading prices, CASBF is priced at $6.26, while APNHY trades at $5.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CASBF currently has a P/E ratio of -29.81, whereas APNHY's P/E ratio is 10.42. In terms of profitability, CASBF's ROE is -0.04%, compared to APNHY's ROE of +0.05%. Regarding short-term risk, CASBF is less volatile compared to APNHY. This indicates potentially lower risk in terms of short-term price fluctuations for CASBF.Check APNHY's competition here
CASBF vs THCBF Comparison August 2025
CASBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CASBF stands at 2.2B. In comparison, THCBF has a market cap of 2.4B. Regarding current trading prices, CASBF is priced at $6.26, while THCBF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CASBF currently has a P/E ratio of -29.81, whereas THCBF's P/E ratio is -0.10. In terms of profitability, CASBF's ROE is -0.04%, compared to THCBF's ROE of +0.00%. Regarding short-term risk, CASBF is less volatile compared to THCBF. This indicates potentially lower risk in terms of short-term price fluctuations for CASBF.Check THCBF's competition here
CASBF vs CURLF Comparison August 2025
CASBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CASBF stands at 2.2B. In comparison, CURLF has a market cap of 2.2B. Regarding current trading prices, CASBF is priced at $6.26, while CURLF trades at $2.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CASBF currently has a P/E ratio of -29.81, whereas CURLF's P/E ratio is -8.14. In terms of profitability, CASBF's ROE is -0.04%, compared to CURLF's ROE of -0.29%. Regarding short-term risk, CASBF is less volatile compared to CURLF. This indicates potentially lower risk in terms of short-term price fluctuations for CASBF.Check CURLF's competition here
CASBF vs DMPHF Comparison August 2025
CASBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CASBF stands at 2.2B. In comparison, DMPHF has a market cap of 2.1B. Regarding current trading prices, CASBF is priced at $6.26, while DMPHF trades at $39.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CASBF currently has a P/E ratio of -29.81, whereas DMPHF's P/E ratio is 17.90. In terms of profitability, CASBF's ROE is -0.04%, compared to DMPHF's ROE of +0.17%. Regarding short-term risk, CASBF is less volatile compared to DMPHF. This indicates potentially lower risk in terms of short-term price fluctuations for CASBF.Check DMPHF's competition here
CASBF vs HTSUF Comparison August 2025
CASBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CASBF stands at 2.2B. In comparison, HTSUF has a market cap of 2.1B. Regarding current trading prices, CASBF is priced at $6.26, while HTSUF trades at $29.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CASBF currently has a P/E ratio of -29.81, whereas HTSUF's P/E ratio is 16.11. In terms of profitability, CASBF's ROE is -0.04%, compared to HTSUF's ROE of +0.08%. Regarding short-term risk, CASBF and HTSUF have similar daily volatility (0.00).Check HTSUF's competition here
CASBF vs LJUIF Comparison August 2025
CASBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CASBF stands at 2.2B. In comparison, LJUIF has a market cap of 2.1B. Regarding current trading prices, CASBF is priced at $6.26, while LJUIF trades at $0.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CASBF currently has a P/E ratio of -29.81, whereas LJUIF's P/E ratio is 13.97. In terms of profitability, CASBF's ROE is -0.04%, compared to LJUIF's ROE of +0.15%. Regarding short-term risk, CASBF and LJUIF have similar daily volatility (0.00).Check LJUIF's competition here
CASBF vs GTBIF Comparison August 2025
CASBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CASBF stands at 2.2B. In comparison, GTBIF has a market cap of 2B. Regarding current trading prices, CASBF is priced at $6.26, while GTBIF trades at $8.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CASBF currently has a P/E ratio of -29.81, whereas GTBIF's P/E ratio is 78.09. In terms of profitability, CASBF's ROE is -0.04%, compared to GTBIF's ROE of +0.02%. Regarding short-term risk, CASBF is less volatile compared to GTBIF. This indicates potentially lower risk in terms of short-term price fluctuations for CASBF.Check GTBIF's competition here
CASBF vs TSMRF Comparison August 2025
CASBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CASBF stands at 2.2B. In comparison, TSMRF has a market cap of 1.9B. Regarding current trading prices, CASBF is priced at $6.26, while TSMRF trades at $25.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CASBF currently has a P/E ratio of -29.81, whereas TSMRF's P/E ratio is 8.66. In terms of profitability, CASBF's ROE is -0.04%, compared to TSMRF's ROE of +0.11%. Regarding short-term risk, CASBF is less volatile compared to TSMRF. This indicates potentially lower risk in terms of short-term price fluctuations for CASBF.Check TSMRF's competition here
CASBF vs ARSUF Comparison August 2025
CASBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CASBF stands at 2.2B. In comparison, ARSUF has a market cap of 1.8B. Regarding current trading prices, CASBF is priced at $6.26, while ARSUF trades at $25.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CASBF currently has a P/E ratio of -29.81, whereas ARSUF's P/E ratio is 22.70. In terms of profitability, CASBF's ROE is -0.04%, compared to ARSUF's ROE of +0.17%. Regarding short-term risk, CASBF and ARSUF have similar daily volatility (0.00).Check ARSUF's competition here
CASBF vs NPNKF Comparison August 2025
CASBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CASBF stands at 2.2B. In comparison, NPNKF has a market cap of 1.7B. Regarding current trading prices, CASBF is priced at $6.26, while NPNKF trades at $25.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CASBF currently has a P/E ratio of -29.81, whereas NPNKF's P/E ratio is 7.82. In terms of profitability, CASBF's ROE is -0.04%, compared to NPNKF's ROE of +0.14%. Regarding short-term risk, CASBF is less volatile compared to NPNKF. This indicates potentially lower risk in terms of short-term price fluctuations for CASBF.Check NPNKF's competition here
CASBF vs MITPF Comparison August 2025
CASBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CASBF stands at 2.2B. In comparison, MITPF has a market cap of 1.6B. Regarding current trading prices, CASBF is priced at $6.26, while MITPF trades at $23.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CASBF currently has a P/E ratio of -29.81, whereas MITPF's P/E ratio is -10.81. In terms of profitability, CASBF's ROE is -0.04%, compared to MITPF's ROE of +4.92%. Regarding short-term risk, CASBF is less volatile compared to MITPF. This indicates potentially lower risk in terms of short-term price fluctuations for CASBF.Check MITPF's competition here
CASBF vs TCNNF Comparison August 2025
CASBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CASBF stands at 2.2B. In comparison, TCNNF has a market cap of 1.5B. Regarding current trading prices, CASBF is priced at $6.26, while TCNNF trades at $8.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CASBF currently has a P/E ratio of -29.81, whereas TCNNF's P/E ratio is -9.92. In terms of profitability, CASBF's ROE is -0.04%, compared to TCNNF's ROE of -0.13%. Regarding short-term risk, CASBF is less volatile compared to TCNNF. This indicates potentially lower risk in terms of short-term price fluctuations for CASBF.Check TCNNF's competition here
CASBF vs KARBF Comparison August 2025
CASBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CASBF stands at 2.2B. In comparison, KARBF has a market cap of 1.5B. Regarding current trading prices, CASBF is priced at $6.26, while KARBF trades at $5.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CASBF currently has a P/E ratio of -29.81, whereas KARBF's P/E ratio is 262.50. In terms of profitability, CASBF's ROE is -0.04%, compared to KARBF's ROE of N/A. Regarding short-term risk, CASBF and KARBF have similar daily volatility (0.00).Check KARBF's competition here
CASBF vs NPPNY Comparison August 2025
CASBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CASBF stands at 2.2B. In comparison, NPPNY has a market cap of 1.4B. Regarding current trading prices, CASBF is priced at $6.26, while NPPNY trades at $5.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CASBF currently has a P/E ratio of -29.81, whereas NPPNY's P/E ratio is 6.55. In terms of profitability, CASBF's ROE is -0.04%, compared to NPPNY's ROE of +0.14%. Regarding short-term risk, CASBF is less volatile compared to NPPNY. This indicates potentially lower risk in terms of short-term price fluctuations for CASBF.Check NPPNY's competition here
CASBF vs SHEZF Comparison August 2025
CASBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CASBF stands at 2.2B. In comparison, SHEZF has a market cap of 1.4B. Regarding current trading prices, CASBF is priced at $6.26, while SHEZF trades at $0.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CASBF currently has a P/E ratio of -29.81, whereas SHEZF's P/E ratio is -23.48. In terms of profitability, CASBF's ROE is -0.04%, compared to SHEZF's ROE of +0.05%. Regarding short-term risk, CASBF is less volatile compared to SHEZF. This indicates potentially lower risk in terms of short-term price fluctuations for CASBF.Check SHEZF's competition here
CASBF vs CHIZF Comparison August 2025
CASBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CASBF stands at 2.2B. In comparison, CHIZF has a market cap of 1.4B. Regarding current trading prices, CASBF is priced at $6.26, while CHIZF trades at $0.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CASBF currently has a P/E ratio of -29.81, whereas CHIZF's P/E ratio is 13.75. In terms of profitability, CASBF's ROE is -0.04%, compared to CHIZF's ROE of +0.00%. Regarding short-term risk, CASBF and CHIZF have similar daily volatility (0.00).Check CHIZF's competition here
CASBF vs SWGHF Comparison August 2025
CASBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CASBF stands at 2.2B. In comparison, SWGHF has a market cap of 1.3B. Regarding current trading prices, CASBF is priced at $6.26, while SWGHF trades at $11.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CASBF currently has a P/E ratio of -29.81, whereas SWGHF's P/E ratio is 15.57. In terms of profitability, CASBF's ROE is -0.04%, compared to SWGHF's ROE of +0.12%. Regarding short-term risk, CASBF and SWGHF have similar daily volatility (0.00).Check SWGHF's competition here
CASBF vs KSPHF Comparison August 2025
CASBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CASBF stands at 2.2B. In comparison, KSPHF has a market cap of 1.3B. Regarding current trading prices, CASBF is priced at $6.26, while KSPHF trades at $30.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CASBF currently has a P/E ratio of -29.81, whereas KSPHF's P/E ratio is 16.28. In terms of profitability, CASBF's ROE is -0.04%, compared to KSPHF's ROE of +0.06%. Regarding short-term risk, CASBF and KSPHF have similar daily volatility (0.00).Check KSPHF's competition here
CASBF vs EVOTF Comparison August 2025
CASBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CASBF stands at 2.2B. In comparison, EVOTF has a market cap of 1.3B. Regarding current trading prices, CASBF is priced at $6.26, while EVOTF trades at $7.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CASBF currently has a P/E ratio of -29.81, whereas EVOTF's P/E ratio is -6.91. In terms of profitability, CASBF's ROE is -0.04%, compared to EVOTF's ROE of -0.17%. Regarding short-term risk, CASBF and EVOTF have similar daily volatility (0.00).Check EVOTF's competition here
CASBF vs GNMLF Comparison August 2025
CASBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CASBF stands at 2.2B. In comparison, GNMLF has a market cap of 1.2B. Regarding current trading prices, CASBF is priced at $6.26, while GNMLF trades at $1.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CASBF currently has a P/E ratio of -29.81, whereas GNMLF's P/E ratio is 11.70. In terms of profitability, CASBF's ROE is -0.04%, compared to GNMLF's ROE of +0.12%. Regarding short-term risk, CASBF and GNMLF have similar daily volatility (0.00).Check GNMLF's competition here
CASBF vs KKPCF Comparison August 2025
CASBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CASBF stands at 2.2B. In comparison, KKPCF has a market cap of 1.1B. Regarding current trading prices, CASBF is priced at $6.26, while KKPCF trades at $28.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CASBF currently has a P/E ratio of -29.81, whereas KKPCF's P/E ratio is 11.24. In terms of profitability, CASBF's ROE is -0.04%, compared to KKPCF's ROE of +0.09%. Regarding short-term risk, CASBF is less volatile compared to KKPCF. This indicates potentially lower risk in terms of short-term price fluctuations for CASBF.Check KKPCF's competition here
CASBF vs NIKA Comparison August 2025
CASBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CASBF stands at 2.2B. In comparison, NIKA has a market cap of 972.9M. Regarding current trading prices, CASBF is priced at $6.26, while NIKA trades at $0.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CASBF currently has a P/E ratio of -29.81, whereas NIKA's P/E ratio is N/A. In terms of profitability, CASBF's ROE is -0.04%, compared to NIKA's ROE of +0.23%. Regarding short-term risk, CASBF is less volatile compared to NIKA. This indicates potentially lower risk in terms of short-term price fluctuations for CASBF.Check NIKA's competition here
CASBF vs BIOGY Comparison August 2025
CASBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CASBF stands at 2.2B. In comparison, BIOGY has a market cap of 961M. Regarding current trading prices, CASBF is priced at $6.26, while BIOGY trades at $9.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CASBF currently has a P/E ratio of -29.81, whereas BIOGY's P/E ratio is 32.76. In terms of profitability, CASBF's ROE is -0.04%, compared to BIOGY's ROE of +0.18%. Regarding short-term risk, CASBF is less volatile compared to BIOGY. This indicates potentially lower risk in terms of short-term price fluctuations for CASBF.Check BIOGY's competition here
CASBF vs SHPHF Comparison August 2025
CASBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CASBF stands at 2.2B. In comparison, SHPHF has a market cap of 924.4M. Regarding current trading prices, CASBF is priced at $6.26, while SHPHF trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CASBF currently has a P/E ratio of -29.81, whereas SHPHF's P/E ratio is -3.33. In terms of profitability, CASBF's ROE is -0.04%, compared to SHPHF's ROE of -0.05%. Regarding short-term risk, CASBF is less volatile compared to SHPHF. This indicates potentially lower risk in terms of short-term price fluctuations for CASBF.Check SHPHF's competition here
CASBF vs LVTTF Comparison August 2025
CASBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CASBF stands at 2.2B. In comparison, LVTTF has a market cap of 891.8M. Regarding current trading prices, CASBF is priced at $6.26, while LVTTF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CASBF currently has a P/E ratio of -29.81, whereas LVTTF's P/E ratio is -0.02. In terms of profitability, CASBF's ROE is -0.04%, compared to LVTTF's ROE of +0.00%. Regarding short-term risk, CASBF is less volatile compared to LVTTF. This indicates potentially lower risk in terms of short-term price fluctuations for CASBF.Check LVTTF's competition here
CASBF vs EVRRF Comparison August 2025
CASBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CASBF stands at 2.2B. In comparison, EVRRF has a market cap of 887.9M. Regarding current trading prices, CASBF is priced at $6.26, while EVRRF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CASBF currently has a P/E ratio of -29.81, whereas EVRRF's P/E ratio is -0.08. In terms of profitability, CASBF's ROE is -0.04%, compared to EVRRF's ROE of +2.97%. Regarding short-term risk, CASBF and EVRRF have similar daily volatility (0.00).Check EVRRF's competition here
CASBF vs NRXCF Comparison August 2025
CASBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CASBF stands at 2.2B. In comparison, NRXCF has a market cap of 842.5M. Regarding current trading prices, CASBF is priced at $6.26, while NRXCF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CASBF currently has a P/E ratio of -29.81, whereas NRXCF's P/E ratio is -0.22. In terms of profitability, CASBF's ROE is -0.04%, compared to NRXCF's ROE of +2.32%. Regarding short-term risk, CASBF and NRXCF have similar daily volatility (0.00).Check NRXCF's competition here
CASBF vs TWAPF Comparison August 2025
CASBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CASBF stands at 2.2B. In comparison, TWAPF has a market cap of 828.5M. Regarding current trading prices, CASBF is priced at $6.26, while TWAPF trades at $16.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CASBF currently has a P/E ratio of -29.81, whereas TWAPF's P/E ratio is 6.28. In terms of profitability, CASBF's ROE is -0.04%, compared to TWAPF's ROE of +0.11%. Regarding short-term risk, CASBF is less volatile compared to TWAPF. This indicates potentially lower risk in terms of short-term price fluctuations for CASBF.Check TWAPF's competition here
CASBF vs CSWYF Comparison August 2025
CASBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CASBF stands at 2.2B. In comparison, CSWYF has a market cap of 758.4M. Regarding current trading prices, CASBF is priced at $6.26, while CSWYF trades at $1.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CASBF currently has a P/E ratio of -29.81, whereas CSWYF's P/E ratio is 4.78. In terms of profitability, CASBF's ROE is -0.04%, compared to CSWYF's ROE of +0.04%. Regarding short-term risk, CASBF is less volatile compared to CSWYF. This indicates potentially lower risk in terms of short-term price fluctuations for CASBF.Check CSWYF's competition here
CASBF vs TRXPF Comparison August 2025
CASBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CASBF stands at 2.2B. In comparison, TRXPF has a market cap of 690.8M. Regarding current trading prices, CASBF is priced at $6.26, while TRXPF trades at $24.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CASBF currently has a P/E ratio of -29.81, whereas TRXPF's P/E ratio is 25.86. In terms of profitability, CASBF's ROE is -0.04%, compared to TRXPF's ROE of +0.03%. Regarding short-term risk, CASBF and TRXPF have similar daily volatility (0.00).Check TRXPF's competition here
CASBF vs SWDCF Comparison August 2025
CASBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CASBF stands at 2.2B. In comparison, SWDCF has a market cap of 671.3M. Regarding current trading prices, CASBF is priced at $6.26, while SWDCF trades at $4.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CASBF currently has a P/E ratio of -29.81, whereas SWDCF's P/E ratio is 105.00. In terms of profitability, CASBF's ROE is -0.04%, compared to SWDCF's ROE of +0.01%. Regarding short-term risk, CASBF and SWDCF have similar daily volatility (0.00).Check SWDCF's competition here
CASBF vs YIHCF Comparison August 2025
CASBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CASBF stands at 2.2B. In comparison, YIHCF has a market cap of 643.1M. Regarding current trading prices, CASBF is priced at $6.26, while YIHCF trades at $0.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CASBF currently has a P/E ratio of -29.81, whereas YIHCF's P/E ratio is -5.00. In terms of profitability, CASBF's ROE is -0.04%, compared to YIHCF's ROE of +0.06%. Regarding short-term risk, CASBF and YIHCF have similar daily volatility (0.00).Check YIHCF's competition here
CASBF vs TRSSF Comparison August 2025
CASBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CASBF stands at 2.2B. In comparison, TRSSF has a market cap of 601.9M. Regarding current trading prices, CASBF is priced at $6.26, while TRSSF trades at $1.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CASBF currently has a P/E ratio of -29.81, whereas TRSSF's P/E ratio is -1.32. In terms of profitability, CASBF's ROE is -0.04%, compared to TRSSF's ROE of -0.70%. Regarding short-term risk, CASBF is less volatile compared to TRSSF. This indicates potentially lower risk in terms of short-term price fluctuations for CASBF.Check TRSSF's competition here
CASBF vs AIHLF Comparison August 2025
CASBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CASBF stands at 2.2B. In comparison, AIHLF has a market cap of 593.1M. Regarding current trading prices, CASBF is priced at $6.26, while AIHLF trades at $3.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CASBF currently has a P/E ratio of -29.81, whereas AIHLF's P/E ratio is 12.50. In terms of profitability, CASBF's ROE is -0.04%, compared to AIHLF's ROE of +0.15%. Regarding short-term risk, CASBF and AIHLF have similar daily volatility (0.00).Check AIHLF's competition here
CASBF vs VRNOF Comparison August 2025
CASBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CASBF stands at 2.2B. In comparison, VRNOF has a market cap of 582.5M. Regarding current trading prices, CASBF is priced at $6.26, while VRNOF trades at $1.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CASBF currently has a P/E ratio of -29.81, whereas VRNOF's P/E ratio is -1.63. In terms of profitability, CASBF's ROE is -0.04%, compared to VRNOF's ROE of -0.27%. Regarding short-term risk, CASBF is less volatile compared to VRNOF. This indicates potentially lower risk in terms of short-term price fluctuations for CASBF.Check VRNOF's competition here
CASBF vs ELTP Comparison August 2025
CASBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CASBF stands at 2.2B. In comparison, ELTP has a market cap of 579.4M. Regarding current trading prices, CASBF is priced at $6.26, while ELTP trades at $0.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CASBF currently has a P/E ratio of -29.81, whereas ELTP's P/E ratio is -54.10. In terms of profitability, CASBF's ROE is -0.04%, compared to ELTP's ROE of -0.23%. Regarding short-term risk, CASBF is less volatile compared to ELTP. This indicates potentially lower risk in terms of short-term price fluctuations for CASBF.Check ELTP's competition here
CASBF vs GLASF Comparison August 2025
CASBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CASBF stands at 2.2B. In comparison, GLASF has a market cap of 564.8M. Regarding current trading prices, CASBF is priced at $6.26, while GLASF trades at $8.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CASBF currently has a P/E ratio of -29.81, whereas GLASF's P/E ratio is -66.67. In terms of profitability, CASBF's ROE is -0.04%, compared to GLASF's ROE of +0.06%. Regarding short-term risk, CASBF is less volatile compared to GLASF. This indicates potentially lower risk in terms of short-term price fluctuations for CASBF.Check GLASF's competition here
CASBF vs PKBFF Comparison August 2025
CASBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CASBF stands at 2.2B. In comparison, PKBFF has a market cap of 544.7M. Regarding current trading prices, CASBF is priced at $6.26, while PKBFF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CASBF currently has a P/E ratio of -29.81, whereas PKBFF's P/E ratio is N/A. In terms of profitability, CASBF's ROE is -0.04%, compared to PKBFF's ROE of +7.96%. Regarding short-term risk, CASBF and PKBFF have similar daily volatility (0.00).Check PKBFF's competition here
CASBF vs CCHWF Comparison August 2025
CASBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CASBF stands at 2.2B. In comparison, CCHWF has a market cap of 521.3M. Regarding current trading prices, CASBF is priced at $6.26, while CCHWF trades at $0.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CASBF currently has a P/E ratio of -29.81, whereas CCHWF's P/E ratio is -1.12. In terms of profitability, CASBF's ROE is -0.04%, compared to CCHWF's ROE of -0.29%. Regarding short-term risk, CASBF is less volatile compared to CCHWF. This indicates potentially lower risk in terms of short-term price fluctuations for CASBF.Check CCHWF's competition here
CASBF vs KHTRF Comparison August 2025
CASBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CASBF stands at 2.2B. In comparison, KHTRF has a market cap of 464.4M. Regarding current trading prices, CASBF is priced at $6.26, while KHTRF trades at $4.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CASBF currently has a P/E ratio of -29.81, whereas KHTRF's P/E ratio is 66.57. In terms of profitability, CASBF's ROE is -0.04%, compared to KHTRF's ROE of +0.00%. Regarding short-term risk, CASBF is less volatile compared to KHTRF. This indicates potentially lower risk in terms of short-term price fluctuations for CASBF.Check KHTRF's competition here
CASBF vs PEXXF Comparison August 2025
CASBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CASBF stands at 2.2B. In comparison, PEXXF has a market cap of 463.1M. Regarding current trading prices, CASBF is priced at $6.26, while PEXXF trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CASBF currently has a P/E ratio of -29.81, whereas PEXXF's P/E ratio is 9.00. In terms of profitability, CASBF's ROE is -0.04%, compared to PEXXF's ROE of N/A. Regarding short-term risk, CASBF and PEXXF have similar daily volatility (0.00).Check PEXXF's competition here
CASBF vs CRLBF Comparison August 2025
CASBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CASBF stands at 2.2B. In comparison, CRLBF has a market cap of 429M. Regarding current trading prices, CASBF is priced at $6.26, while CRLBF trades at $1.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CASBF currently has a P/E ratio of -29.81, whereas CRLBF's P/E ratio is -9.07. In terms of profitability, CASBF's ROE is -0.04%, compared to CRLBF's ROE of -0.10%. Regarding short-term risk, CASBF is less volatile compared to CRLBF. This indicates potentially lower risk in terms of short-term price fluctuations for CASBF.Check CRLBF's competition here
CASBF vs BOIRF Comparison August 2025
CASBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CASBF stands at 2.2B. In comparison, BOIRF has a market cap of 421.9M. Regarding current trading prices, CASBF is priced at $6.26, while BOIRF trades at $24.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CASBF currently has a P/E ratio of -29.81, whereas BOIRF's P/E ratio is 31.97. In terms of profitability, CASBF's ROE is -0.04%, compared to BOIRF's ROE of +0.03%. Regarding short-term risk, CASBF is less volatile compared to BOIRF. This indicates potentially lower risk in terms of short-term price fluctuations for CASBF.Check BOIRF's competition here
CASBF vs AGYTF Comparison August 2025
CASBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CASBF stands at 2.2B. In comparison, AGYTF has a market cap of 405.1M. Regarding current trading prices, CASBF is priced at $6.26, while AGYTF trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CASBF currently has a P/E ratio of -29.81, whereas AGYTF's P/E ratio is -8.50. In terms of profitability, CASBF's ROE is -0.04%, compared to AGYTF's ROE of -13.93%. Regarding short-term risk, CASBF is less volatile compared to AGYTF. This indicates potentially lower risk in terms of short-term price fluctuations for CASBF.Check AGYTF's competition here
CASBF vs HUMDF Comparison August 2025
CASBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CASBF stands at 2.2B. In comparison, HUMDF has a market cap of 404.2M. Regarding current trading prices, CASBF is priced at $6.26, while HUMDF trades at $0.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CASBF currently has a P/E ratio of -29.81, whereas HUMDF's P/E ratio is -13.69. In terms of profitability, CASBF's ROE is -0.04%, compared to HUMDF's ROE of +2.11%. Regarding short-term risk, CASBF and HUMDF have similar daily volatility (0.00).Check HUMDF's competition here
CASBF vs CPHRF Comparison August 2025
CASBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CASBF stands at 2.2B. In comparison, CPHRF has a market cap of 279.6M. Regarding current trading prices, CASBF is priced at $6.26, while CPHRF trades at $10.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CASBF currently has a P/E ratio of -29.81, whereas CPHRF's P/E ratio is 23.72. In terms of profitability, CASBF's ROE is -0.04%, compared to CPHRF's ROE of +0.12%. Regarding short-term risk, CASBF is less volatile compared to CPHRF. This indicates potentially lower risk in terms of short-term price fluctuations for CASBF.Check CPHRF's competition here
CASBF vs BHCCF Comparison August 2025
CASBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CASBF stands at 2.2B. In comparison, BHCCF has a market cap of 225.1M. Regarding current trading prices, CASBF is priced at $6.26, while BHCCF trades at $0.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CASBF currently has a P/E ratio of -29.81, whereas BHCCF's P/E ratio is -4.57. In terms of profitability, CASBF's ROE is -0.04%, compared to BHCCF's ROE of +0.19%. Regarding short-term risk, CASBF is less volatile compared to BHCCF. This indicates potentially lower risk in terms of short-term price fluctuations for CASBF.Check BHCCF's competition here
CASBF vs BIOIF Comparison August 2025
CASBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CASBF stands at 2.2B. In comparison, BIOIF has a market cap of 204.2M. Regarding current trading prices, CASBF is priced at $6.26, while BIOIF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CASBF currently has a P/E ratio of -29.81, whereas BIOIF's P/E ratio is -0.02. In terms of profitability, CASBF's ROE is -0.04%, compared to BIOIF's ROE of -10.85%. Regarding short-term risk, CASBF and BIOIF have similar daily volatility (0.00).Check BIOIF's competition here
CASBF vs PLNHF Comparison August 2025
CASBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CASBF stands at 2.2B. In comparison, PLNHF has a market cap of 202M. Regarding current trading prices, CASBF is priced at $6.26, while PLNHF trades at $0.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CASBF currently has a P/E ratio of -29.81, whereas PLNHF's P/E ratio is -3.50. In terms of profitability, CASBF's ROE is -0.04%, compared to PLNHF's ROE of -0.41%. Regarding short-term risk, CASBF is less volatile compared to PLNHF. This indicates potentially lower risk in terms of short-term price fluctuations for CASBF.Check PLNHF's competition here
CASBF vs CBWTF Comparison August 2025
CASBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CASBF stands at 2.2B. In comparison, CBWTF has a market cap of 157.4M. Regarding current trading prices, CASBF is priced at $6.26, while CBWTF trades at $0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CASBF currently has a P/E ratio of -29.81, whereas CBWTF's P/E ratio is 11.71. In terms of profitability, CASBF's ROE is -0.04%, compared to CBWTF's ROE of +0.20%. Regarding short-term risk, CASBF is less volatile compared to CBWTF. This indicates potentially lower risk in terms of short-term price fluctuations for CASBF.Check CBWTF's competition here
CASBF vs PHCUF Comparison August 2025
CASBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CASBF stands at 2.2B. In comparison, PHCUF has a market cap of 156.6M. Regarding current trading prices, CASBF is priced at $6.26, while PHCUF trades at $5.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CASBF currently has a P/E ratio of -29.81, whereas PHCUF's P/E ratio is -293.74. In terms of profitability, CASBF's ROE is -0.04%, compared to PHCUF's ROE of -0.01%. Regarding short-term risk, CASBF is less volatile compared to PHCUF. This indicates potentially lower risk in terms of short-term price fluctuations for CASBF.Check PHCUF's competition here
CASBF vs AAWH Comparison August 2025
CASBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CASBF stands at 2.2B. In comparison, AAWH has a market cap of 146.2M. Regarding current trading prices, CASBF is priced at $6.26, while AAWH trades at $0.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CASBF currently has a P/E ratio of -29.81, whereas AAWH's P/E ratio is -1.71. In terms of profitability, CASBF's ROE is -0.04%, compared to AAWH's ROE of -1.49%. Regarding short-term risk, CASBF is less volatile compared to AAWH. This indicates potentially lower risk in terms of short-term price fluctuations for CASBF.Check AAWH's competition here
CASBF vs JUSHF Comparison August 2025
CASBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CASBF stands at 2.2B. In comparison, JUSHF has a market cap of 133.8M. Regarding current trading prices, CASBF is priced at $6.26, while JUSHF trades at $0.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CASBF currently has a P/E ratio of -29.81, whereas JUSHF's P/E ratio is -2.27. In terms of profitability, CASBF's ROE is -0.04%, compared to JUSHF's ROE of +0.99%. Regarding short-term risk, CASBF is less volatile compared to JUSHF. This indicates potentially lower risk in terms of short-term price fluctuations for CASBF.Check JUSHF's competition here
CASBF vs COPHF Comparison August 2025
CASBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CASBF stands at 2.2B. In comparison, COPHF has a market cap of 131.7M. Regarding current trading prices, CASBF is priced at $6.26, while COPHF trades at $0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CASBF currently has a P/E ratio of -29.81, whereas COPHF's P/E ratio is -0.02. In terms of profitability, CASBF's ROE is -0.04%, compared to COPHF's ROE of -5.75%. Regarding short-term risk, CASBF is less volatile compared to COPHF. This indicates potentially lower risk in terms of short-term price fluctuations for CASBF.Check COPHF's competition here
CASBF vs STMH Comparison August 2025
CASBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CASBF stands at 2.2B. In comparison, STMH has a market cap of 125.6M. Regarding current trading prices, CASBF is priced at $6.26, while STMH trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CASBF currently has a P/E ratio of -29.81, whereas STMH's P/E ratio is N/A. In terms of profitability, CASBF's ROE is -0.04%, compared to STMH's ROE of -2.75%. Regarding short-term risk, CASBF is less volatile compared to STMH. This indicates potentially lower risk in terms of short-term price fluctuations for CASBF.Check STMH's competition here
CASBF vs NWPN Comparison August 2025
CASBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CASBF stands at 2.2B. In comparison, NWPN has a market cap of 123.7M. Regarding current trading prices, CASBF is priced at $6.26, while NWPN trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CASBF currently has a P/E ratio of -29.81, whereas NWPN's P/E ratio is -0.04. In terms of profitability, CASBF's ROE is -0.04%, compared to NWPN's ROE of +0.13%. Regarding short-term risk, CASBF is less volatile compared to NWPN. This indicates potentially lower risk in terms of short-term price fluctuations for CASBF.Check NWPN's competition here
CASBF vs LOVFF Comparison August 2025
CASBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CASBF stands at 2.2B. In comparison, LOVFF has a market cap of 123.4M. Regarding current trading prices, CASBF is priced at $6.26, while LOVFF trades at $1.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CASBF currently has a P/E ratio of -29.81, whereas LOVFF's P/E ratio is 11.25. In terms of profitability, CASBF's ROE is -0.04%, compared to LOVFF's ROE of +0.17%. Regarding short-term risk, CASBF is less volatile compared to LOVFF. This indicates potentially lower risk in terms of short-term price fluctuations for CASBF.Check LOVFF's competition here
CASBF vs HLTRF Comparison August 2025
CASBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CASBF stands at 2.2B. In comparison, HLTRF has a market cap of 119.3M. Regarding current trading prices, CASBF is priced at $6.26, while HLTRF trades at $3.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CASBF currently has a P/E ratio of -29.81, whereas HLTRF's P/E ratio is -7.92. In terms of profitability, CASBF's ROE is -0.04%, compared to HLTRF's ROE of -0.21%. Regarding short-term risk, CASBF is less volatile compared to HLTRF. This indicates potentially lower risk in terms of short-term price fluctuations for CASBF.Check HLTRF's competition here
CASBF vs SHIEF Comparison August 2025
CASBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CASBF stands at 2.2B. In comparison, SHIEF has a market cap of 115M. Regarding current trading prices, CASBF is priced at $6.26, while SHIEF trades at $0.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CASBF currently has a P/E ratio of -29.81, whereas SHIEF's P/E ratio is -3.68. In terms of profitability, CASBF's ROE is -0.04%, compared to SHIEF's ROE of -3.96%. Regarding short-term risk, CASBF is less volatile compared to SHIEF. This indicates potentially lower risk in terms of short-term price fluctuations for CASBF.Check SHIEF's competition here
CASBF vs LPCUF Comparison August 2025
CASBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CASBF stands at 2.2B. In comparison, LPCUF has a market cap of 110.8M. Regarding current trading prices, CASBF is priced at $6.26, while LPCUF trades at $0.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CASBF currently has a P/E ratio of -29.81, whereas LPCUF's P/E ratio is 18.82. In terms of profitability, CASBF's ROE is -0.04%, compared to LPCUF's ROE of +0.05%. Regarding short-term risk, CASBF is less volatile compared to LPCUF. This indicates potentially lower risk in terms of short-term price fluctuations for CASBF.Check LPCUF's competition here
CASBF vs CNVCF Comparison August 2025
CASBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CASBF stands at 2.2B. In comparison, CNVCF has a market cap of 109.2M. Regarding current trading prices, CASBF is priced at $6.26, while CNVCF trades at $6.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CASBF currently has a P/E ratio of -29.81, whereas CNVCF's P/E ratio is -5.00. In terms of profitability, CASBF's ROE is -0.04%, compared to CNVCF's ROE of -3.90%. Regarding short-term risk, CASBF and CNVCF have similar daily volatility (0.00).Check CNVCF's competition here
CASBF vs GRUSF Comparison August 2025
CASBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CASBF stands at 2.2B. In comparison, GRUSF has a market cap of 108.6M. Regarding current trading prices, CASBF is priced at $6.26, while GRUSF trades at $0.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CASBF currently has a P/E ratio of -29.81, whereas GRUSF's P/E ratio is 21.75. In terms of profitability, CASBF's ROE is -0.04%, compared to GRUSF's ROE of -0.89%. Regarding short-term risk, CASBF and GRUSF have similar daily volatility (0.00).Check GRUSF's competition here
CASBF vs BIOYF Comparison August 2025
CASBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CASBF stands at 2.2B. In comparison, BIOYF has a market cap of 101M. Regarding current trading prices, CASBF is priced at $6.26, while BIOYF trades at $8.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CASBF currently has a P/E ratio of -29.81, whereas BIOYF's P/E ratio is 18.34. In terms of profitability, CASBF's ROE is -0.04%, compared to BIOYF's ROE of +0.22%. Regarding short-term risk, CASBF is less volatile compared to BIOYF. This indicates potentially lower risk in terms of short-term price fluctuations for CASBF.Check BIOYF's competition here
CASBF vs PLNH Comparison August 2025
CASBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CASBF stands at 2.2B. In comparison, PLNH has a market cap of 94.4M. Regarding current trading prices, CASBF is priced at $6.26, while PLNH trades at $0.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CASBF currently has a P/E ratio of -29.81, whereas PLNH's P/E ratio is -1.81. In terms of profitability, CASBF's ROE is -0.04%, compared to PLNH's ROE of -0.42%. Regarding short-term risk, CASBF is less volatile compared to PLNH. This indicates potentially lower risk in terms of short-term price fluctuations for CASBF.Check PLNH's competition here
CASBF vs LRDSF Comparison August 2025
CASBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CASBF stands at 2.2B. In comparison, LRDSF has a market cap of 83.9M. Regarding current trading prices, CASBF is priced at $6.26, while LRDSF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CASBF currently has a P/E ratio of -29.81, whereas LRDSF's P/E ratio is -0.01. In terms of profitability, CASBF's ROE is -0.04%, compared to LRDSF's ROE of +1.61%. Regarding short-term risk, CASBF is less volatile compared to LRDSF. This indicates potentially lower risk in terms of short-term price fluctuations for CASBF.Check LRDSF's competition here
CASBF vs ABSCF Comparison August 2025
CASBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CASBF stands at 2.2B. In comparison, ABSCF has a market cap of 80.3M. Regarding current trading prices, CASBF is priced at $6.26, while ABSCF trades at $1.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CASBF currently has a P/E ratio of -29.81, whereas ABSCF's P/E ratio is -7.41. In terms of profitability, CASBF's ROE is -0.04%, compared to ABSCF's ROE of +0.32%. Regarding short-term risk, CASBF is less volatile compared to ABSCF. This indicates potentially lower risk in terms of short-term price fluctuations for CASBF.Check ABSCF's competition here